SCHEMBL25094071

SCHEMBL25094071

CC(C)(C)c1cccc(-c2cccc(C(F)(F)F)c2)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 3/20 0.60
RXRA P19793 1/20 0.53
RXRB P28702 1/20 0.53
MAOB P27338 1/20 0.50
KDM1A O60341 1/20 0.49
TSHR P16473 1/20 0.48
MAPK1 P28482 1/20 0.48
IDO1 P14902 1/20 0.47
NOTUM Q6P988 1/20 0.47
ACHE P22303 1/20 0.47
ALDH1A1 P00352 1/20 0.46
GAA P10253 1/20 0.46
ATM Q13315 1/20 0.46
IKBKB O14920 1/20 0.46
PGR P06401 1/20 0.46
BRD4 O60885 1/20 0.46
ASIC3 Q9UHC3 1/20 0.46
SCN2A Q99250 1/20 0.46
GALR1 P47211 1/20 0.45
HTR2C P28335 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16087802 0.90 KIF11 (0.65) KIF11RXRARXRBMAOBKDM1A
SCHEMBL12732284 0.90 KIF11 (0.55) KIF11RXRARXRBMAOBKDM1A
SCHEMBL178282 0.89 TSHR (0.54) KIF11TSHRMAPK1IDO1ACHE
SCHEMBL30023786 0.89 KIF11 (0.72) KIF11RXRARXRBACHEALDH1A1
SCHEMBL29678302 0.89 TSHR (0.58) KIF11MAOBKDM1ATSHRMAPK1
SCHEMBL5547288 0.89 KIF11 (0.72) KIF11RXRARXRBACHEALDH1A1
SCHEMBL1263144 0.89 TSHR (0.58) KIF11MAOBKDM1ATSHRMAPK1
SCHEMBL18210650 0.87 KIF11 (0.60) KIF11RXRARXRBMAOBACHE
SCHEMBL27659191 0.86 KIF11 (0.76) KIF11RXRARXRBACHEALDH1A1
Ammonia Solution, Strong SCHEMBL20472961 0.86 MAOB (0.56) KIF11MAOBKDM1ATSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11648254-B2 Substituted pyrido[2,3-d]pyrimidines as inhibitors of Ras pathway signaling KUMQUAT BIOSCIENCES INC. (US) 2023-05-16 US disclosed
US-11648254-B2 Substituted pyrido[2,3-d]pyrimidines as inhibitors of Ras pathway signaling KUMQUAT BIOSCIENCES INC. (US) 2023-05-16 US disclosed
US-20230064360-A1 HETEROCYCLES AND USES THEREOF KUMQUAT BIOSCIENCES INC. 2023-03-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11648254-B2 Substituted pyrido[2,3-d]pyrimidines as inhibitors of Ras pathway signaling KRAS, NRAS, BRAF KIF11 3998/4885RXRA 2426/4885RXRB 1594/4885
US-20230064360-A1 HETEROCYCLES AND USES THEREOF KRAS, HRAS, TP53 KIF11 4463/4885RXRA 2624/4885RXRB 2300/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.